Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients

Journal of the American Society of Nephrology

Volumn 13, Issue 5, 2002, Pages 1331-1337

  Skoupy, Sonja ^a   Födinger, Manuela ^a   Veitl, Mario ^a   Perschl, Agnes ^a   Puttinger, Heidi ^a   Röhrer, Claudia ^a   Schindler, Karin ^a   Vychytil, Andreas ^a   Hörl, Walter H ^a   Sunder Plassmann, Gere ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; RIBOFLAVIN; THIAMINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ERYTHROCYTE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL;

EID: 18344387513     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000013299.11876.F6     Document Type: Article

References (58)

1. Hyperhomocysteinemia in chronic renal disease
2. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
3. Effect of MTHFR 677C→T on plasma total homocysteine levels in renal graft recipients
4. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
5. 12 plasma concentrations in kidney graft recipients
6. Association of two MTHFR polymorphisms with total homocysteine plasma levels in dialysis patients
7. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels
8. 12 and folate deficiency. A guide for the primary care physician
9. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
10. Homocysteine and vascular disease
11. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual?
12. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland homocysteine study
13. Homocysteine metabolism in renal failure
14. ASHG/ACMG statement. Measurement and use of total plasma homocysteine
15. Erythrocyte transketolase activity-micromethod
16. Water soluble vitamins in chronic hemodialysis patients and need for supplementation
17. Effect of flavine compounds on glutathione reductase activity: In vivo and in vitro studies
18. 2-dependent glutathione reductase from human erythrocytes by FAD in vitro. Investigations on the vitamin B 2 status in healthy people and geriatric patients
19. Untersuchung zur bestimmung der α-EGR
20. 6 in the human
21. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
22. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
23. Methionine transamination (Disorders of transsulfuration)
24. Thiamine (vitamin B1) supplementation does not reduce fasting blood homocysteine concentration in most homozygotes for homocystinuria
25. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia
26. The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat
27. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
28. Vitamin intake: A possible determinant of plasma homocyst(e)ine among middle-aged adults
29. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort
30. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetetrahydrofolate reductase C677T polymorphism
31. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: Results among U.S. men
32. Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation
33. Plasma thiamine levels with hemodialysis
34. Water soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients
35. Vitamins and continuous ambulatory peritoneal dialysis (CAPD)
36. 2 and vitamin E in long-term hemodialysis
37. Deranged concentrations of water-soluble vitamins in the blood of undialyzed and dialyzed patients with chronic renal failure
38. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD)
39. Deficiencies of vitamins in CAPD patients: The effect of supplementation
40. Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency
41. 12, serum and erythrocyte folate in peritoneal dialysis patients
42. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients
43. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia
44. Erythrocyte transketolase activity in uremia
45. Elevated plasma vitamers of vitamin B6 in patients with chronic renal failure on regular haemodialysis
46. Vitamin status of pediatric patients receiving long-term peritoneal dialysis
47. Vitamin status of infants receiving long-term peritoneal dialysis
48. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation
49. Vitamin nutrition in patients undergoing maintenance hemodialysis
50. Vitamin levels in chronic renal failure and need for supplementation
51. Vitamin nutrition in patients with chronic renal failure and dietary manipulation
52. Trace elements and vitamins in renal disease
53. Fehlen dialysepatienten wasserlösliche vitamine?
54. Thiamin
55. Riboflavin
56. 6
57. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation
58. 6 deficiency in uremia